Excited to share our new publication: Neurochemical and Behavioral Evidence of High Abuse Liability of 3F-NEB, a Novel Synthetic Cathinone Grateful for the support and teamwork during this journey. @msolinas.bsky.social Read it here: www.sciencedirect.com/science/arti...

Check out our new article on the neuroprotective effects of AD4 against paraoxon intoxication. Read it here 📖: www.mdpi.com/2076-3921/14... Congratulations Edurne and team!!🎉

Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights Read it here: pubs.acs.org/doi/10.1021/...

Our new study regarding the psychoplastogenic properties and antidepressant effects of 25C-NBF, a selective 5-HT2A agonist, was published a few days ago in Molecular Psychiatry! Huge thanks to the whole team! www.nature.com/articles/s41... @farmaciaub.bsky.social @ub.edu

Our new study characterizes 25C-NBF as a selective 5-HT2A agonist with psychoplastogenic and rapid antidepressant-like effects in rodents. So excited to see this work published in Molecular Psychiatry! Read it here: www.nature.com/articles/s41...

¿Imagina poder comprar una droga por internet y que llegue a su casa por correo? Pues la opción existe. Y no es una sola, sino cientos. @ub.edu 

La I Jornada d’Investigació Psicodèlica va ser tot un èxit! 👏 Hi va poder haver un diàleg molt interessant entre preclínics i clínics, on es va posar de manifest el gran potencial terapèutic que tenen aquests compostos. Moltes gràcies a tots!! #PsychedeliCare

In this study, we characterize how halogenated DMT analogs, especially 5-Br-DMT, can trigger neuroplasticity and antidepressant-like effects while minimizing hallucinations.

We’re thrilled to share our paper， recently published in Molecular Psychiatry: “Neuropharmacology of halogenated DMT analogs: psychoplastogenic and antidepressant properties of 5-Br-DMT, a psychedelic derivative with low hallucinogenic potential” 

Excited to share that our book chapter “Psychedelics for the Treatment of Substance Use Disorder” is now published in Psychedelic Drugs – Therapeutic and Recreational Use (IntechOpen)! Read it here: www.intechopen.com/online-first...

Our PhD student Martalu D. Pazos is presenting her poster today at #ECNP2025 ! If you are interested in the psychistumulant and addictive effects of novel second-generation synthetic cathinones, come say hi at PS01-0004 🧠💊

Ens fa molta il·lusió participar en la I Jornada d’Investigació Psicodèlica, on presentarem alguns dels nostres darrers resultats. Creiem que és una gran oportunitat per donar veu a noves opcions terapèutiques basades en l’evidència científica. No us ho perdeu!

📢 Nuevo artículo de divulgación publicado en @es.theconversation.com : Los nitazenos, el peligroso relevo del fentanilo en la crisis de los opioides sintéticos 👉 theconversation.com/los-nitazeno...

Huge congrats to Dr. Pol Puigseslloses for successfully defending his PhD last Friday — the first psychedelic-themed thesis from our group! 🍄 We’re proud of you! #PhDDefense #Psychedelics

Me siento muy afortunada de compartir con vosotros el vídeo de mi participación en: www.tedxcadizuniversity.com/ “Vivir sin drogas, sanar con drogas” 👇 youtu.be/xicRrTlXjh4?...

One of @nurianadalg.bsky.social ‘s undergraduate students surprised her with this fantastic 3D model of the tail suspension test! 🐭🤩 We love seeing such creativity and appreciation from our students.

Big congrats to our PhD student Martalu D. Pazos for winning the science communication contest (Four Minutes Thesis) at the III Doctoral Research and Dissemination Day at the @ub.edu 🎉👏

Hello Bluesky! 👋 We are a research group from @ub.edu focused on the neuropsychopharmacology of emerging psychostimulants and psychedelics. Our work bridges neuroscience and toxicology to better understand how these compounds affect the brain🧠.